BIIB
Price
$123.52
Change
+$2.59 (+2.14%)
Updated
May 2, 04:59 PM (EDT)
Capitalization
31.34B
82 days until earnings call
BYND
Price
$2.51
Change
-$0.00 (-0.00%)
Updated
May 2, 04:59 PM (EDT)
Capitalization
535.53M
5 days until earnings call
Ad is loading...

BIIB vs BYND

Header iconBIIB vs BYND Comparison
Open Charts BIIB vs BYNDBanner chart's image
Biogen
Price$123.52
Change+$2.59 (+2.14%)
Volume$21.98K
Capitalization31.34B
Beyond Meat
Price$2.51
Change-$0.00 (-0.00%)
Volume$17.43K
Capitalization535.53M
BIIB vs BYND Comparison Chart
Loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BYND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIIB vs. BYND commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Hold and BYND is a Hold.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (BIIB: $120.93 vs. BYND: $2.51)
Brand notoriety: BIIB and BYND are both notable
BIIB represents the Pharmaceuticals: Major, while BYND is part of the Food: Specialty/Candy industry
Current volume relative to the 65-day Moving Average: BIIB: 134% vs. BYND: 50%
Market capitalization -- BIIB: $31.34B vs. BYND: $535.53M
BIIB [@Pharmaceuticals: Major] is valued at $31.34B. BYND’s [@Food: Specialty/Candy] market capitalization is $535.53M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Food: Specialty/Candy] industry ranges from $327.81B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Food: Specialty/Candy] industry is $9.28B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 0 FA rating(s) are green whileBYND’s FA Score has 0 green FA rating(s).

  • BIIB’s FA Score: 0 green, 5 red.
  • BYND’s FA Score: 0 green, 5 red.
According to our system of comparison, BIIB is a better buy in the long-term than BYND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 5 TA indicator(s) are bullish while BYND’s TA Score has 5 bullish TA indicator(s).

  • BIIB’s TA Score: 5 bullish, 4 bearish.
  • BYND’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BYND is a better buy in the short-term than BIIB.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а +1.19% price change this week, while BYND (@Food: Specialty/Candy) price change was -1.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.38%. For the same industry, the average monthly price growth was +2.02%, and the average quarterly price growth was -6.49%.

The average weekly price growth across all stocks in the @Food: Specialty/Candy industry was -0.27%. For the same industry, the average monthly price growth was -1.03%, and the average quarterly price growth was -3.81%.

Reported Earning Dates

BIIB is expected to report earnings on Jul 23, 2025.

BYND is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.38% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Food: Specialty/Candy (-0.27% weekly)

A specialty/candy manufacturer specializes in one or more of the following: chocolate, candies, pasta, condiments, seasonings, among other items. Hershey Company, McCormick & Company and J.M. Smucker Company are some of the major firms in this segment. Demand for this industry’s products comes from both institutions/restaurants as well as households.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIIB($31.3B) has a higher market cap than BYND($536M). BIIB YTD gains are higher at: -20.919 vs. BYND (-33.245). BIIB has higher annual earnings (EBITDA): 2.04B vs. BYND (-282.19M). BIIB has more cash in the bank: 1.05B vs. BYND (191M). BYND has less debt than BIIB: BYND (1.22B) vs BIIB (7.34B). BIIB has higher revenues than BYND: BIIB (9.84B) vs BYND (343M).
BIIBBYNDBIIB / BYND
Capitalization31.3B536M5,840%
EBITDA2.04B-282.19M-722%
Gain YTD-20.919-33.24563%
P/E Ratio26.95N/A-
Revenue9.84B343M2,868%
Total Cash1.05B191M550%
Total Debt7.34B1.22B603%
FUNDAMENTALS RATINGS
BIIB vs BYND: Fundamental Ratings
BIIB
BYND
OUTLOOK RATING
1..100
368
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
67100
PRICE GROWTH RATING
1..100
6494
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIIB's Valuation (87) in the Biotechnology industry is in the same range as BYND (89) in the Food Meat Or Fish Or Dairy industry. This means that BIIB’s stock grew similarly to BYND’s over the last 12 months.

BIIB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BYND (100) in the Food Meat Or Fish Or Dairy industry. This means that BIIB’s stock grew similarly to BYND’s over the last 12 months.

BIIB's SMR Rating (67) in the Biotechnology industry is somewhat better than the same rating for BYND (100) in the Food Meat Or Fish Or Dairy industry. This means that BIIB’s stock grew somewhat faster than BYND’s over the last 12 months.

BIIB's Price Growth Rating (64) in the Biotechnology industry is in the same range as BYND (94) in the Food Meat Or Fish Or Dairy industry. This means that BIIB’s stock grew similarly to BYND’s over the last 12 months.

BIIB's P/E Growth Rating (96) in the Biotechnology industry is in the same range as BYND (100) in the Food Meat Or Fish Or Dairy industry. This means that BIIB’s stock grew similarly to BYND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIIBBYND
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
69%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BYND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XAGE0.180.02
+12.50%
Longevity Health Holdings Inc
SAMG15.30N/A
N/A
Silvercrest Asset Management Group
RBA99.95-0.75
-0.74%
RB Global
MITK8.10-0.18
-2.17%
Mitek Systems
JJSF126.66-2.93
-2.26%
J & J Snack Foods Corp

BYND and

Correlation & Price change

A.I.dvisor tells us that BYND and BGS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BYND and BGS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYND
1D Price
Change %
BYND100%
+1.21%
BGS - BYND
30%
Poorly correlated
-1.16%
STKL - BYND
25%
Poorly correlated
-3.70%
HAIN - BYND
25%
Poorly correlated
-3.95%
HLF - BYND
24%
Poorly correlated
-7.92%
CENT - BYND
22%
Poorly correlated
+1.04%
More